Herantis Pharma plc shares subscribed with option rights

Herantis Pharma plc shares subscribed with option rights

Herantis Pharma Plc
Company release 10 Nov 2014 at 11:00 am
Herantis Pharma plc.
Stock exchange release 10 November 2014, 11.00 am

4000 new  shares of Herantis Pharma plc. have been subscribed with option rights
of  the  option  program  2010. New  shares  have been registered into the Trade
Register  on 10 November  2014, as of  which date  the new shares will establish
shareholder rights.

The  share capital will not increase with subscriptions. The entire subscription
price of EUR 0.20 will be entered in the invested unrestricted equity reserve of
the  company. As a  result of the  share subscriptions, the  number of shares of
Herantis Pharma plc. will increase to 4,062,214 shares.

The  new shares  will be  traded on  the NASDAQ  OMX Helsinki  Ltd's First North
marketplace together with the old shares as of 10 November 2014.

Share  information of the  Herantis Pharma plc.  share after the registration of
new shares:

Trading Code: HRTIS
ISIN code: FI4000087861
List: First North Helsinki
Industry: Health Care
Number of Shares: 4,062,214
Share Capital: 80,000.00 euro

Herantis Pharma plc.
Pekka Simula
CEO

Further information:

Herantis Pharma plc., Pekka Simula, CEO, telephone: +358 40 7300 445
Company web site: www.herantis.com
Certified Advisor: UB Capital Oy, telephone: +358 9 2538 0225

About Herantis Pharma plc.

Herantis Pharma plc. is a pharmaceutical company specialised in new drug
research and development. The company focuses on diseases with an unmet clinical
need. These diseases include for example dry eye syndrome, Parkinson's disease,
and secondary lymphedema. We believe our drugs are the first or best in their
class and have the potential to change treatment strategies of diseases. The
shares of Herantis Pharma plc. are listed on the First North Finland marketplace
run by NASDAQ OMX Helsinki stock exchange.